SCIENTURE HOLDINGS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
SCIENTURE HOLDINGS, INC. (SCNX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $408.85 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-10-26
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $384.86K, a 448.81% increase year-over-year.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $18.07K.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $5.92K, a 96.19% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $10.58K.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $169.24K.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$64.03K.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$617.11K, a 199.33% decline from fiscal 2014.
- SCIENTURE HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $621.28K, a 667.60% increase from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $384.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $402.93K derived: sum of 2 quarters · filed 2018-10-26 | $408.85K 10-Q · filed 2018-10-26 | $419.44K derived: sum of 4 quarters · filed 2018-10-26 | ||||
| 2018-06-30 | $18.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $23.99K 10-Q · filed 2018-07-27 | $34.58K derived: sum of 3 quarters · filed 2018-07-27 | $104.70K derived: sum of 4 quarters · filed 2018-10-26 | ||||
| 2018-03-31 | $5.92K 10-Q · filed 2018-04-27 | $16.51K derived: sum of 2 quarters · filed 2018-04-27 | $86.63K derived: sum of 3 quarters · filed 2018-10-26 | $19.84K derived: sum of 4 quarters · filed 2018-10-26 | ||||
| 2017-12-31 | $10.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $80.71K derived: sum of 2 quarters · filed 2018-10-26 | $13.92K derived: sum of 3 quarters · filed 2018-10-26 | $169.24K 10-K · filed 2018-03-02 | ||||
| 2017-09-30 | $70.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $3.33K derived: sum of 2 quarters · filed 2018-10-26 | $158.65K 10-Q · filed 2018-10-26 | $84.27K derived: sum of 4 quarters · filed 2018-10-26 | ||||
| 2017-06-30 | -$66.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $88.53K 10-Q · filed 2018-07-27 | $14.15K derived: sum of 3 quarters · filed 2018-07-27 | $75.56K derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2017-03-31 | $155.32K 10-Q · filed 2018-04-27 | $80.94K derived: sum of 2 quarters · filed 2018-04-27 | $142.35K derived: sum of 3 quarters · filed 2018-04-27 | $158.85K derived: sum of 4 quarters · filed 2018-04-27 | ||||
| 2016-12-31 | -$74.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$12.97K derived: sum of 2 quarters · filed 2018-03-02 | $3.54K derived: sum of 3 quarters · filed 2018-03-02 | -$64.03K 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | $61.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $77.92K derived: sum of 2 quarters · filed 2017-11-07 | $10.35K 10-Q · filed 2017-11-07 | -$765.58K 10-Q · filed 2016-11-14 | -$225.78K derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | $16.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$51.06K 10-Q · filed 2017-08-04 | -$540.54K 10-Q · filed 2016-08-05 | -$287.19K derived: sum of 3 quarters · filed 2017-08-04 | -$376.74K derived: sum of 4 quarters · filed 2017-08-04 | |||
| 2016-03-31 | -$67.57K 10-Q · filed 2017-05-15 | -$351.85K 10-Q · filed 2016-04-20 | -$303.69K derived: sum of 2 quarters · filed 2017-05-15 | -$393.24K derived: sum of 3 quarters · filed 2017-05-15 | -$314.37K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$236.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$325.67K derived: sum of 2 quarters · filed 2017-03-30 | -$246.81K derived: sum of 3 quarters · filed 2017-03-30 | -$617.11K 10-K · filed 2017-03-30 | $154.53K 10-K · filed 2016-03-28 | |||
| 2015-09-30 | -$89.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$10.68K derived: sum of 2 quarters · filed 2016-11-14 | -$380.98K 10-Q · filed 2016-11-14 | $53.77K derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $78.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$291.44K 10-Q · filed 2016-08-05 | $143.32K derived: sum of 3 quarters · filed 2016-08-05 | $343.68K derived: sum of 4 quarters · filed 2016-08-05 | ||||
| 2015-03-31 | -$370.30K 10-Q · filed 2016-04-20 | $64.45K derived: sum of 2 quarters · filed 2016-04-20 | $264.81K derived: sum of 3 quarters · filed 2016-04-20 | $224.98K derived: sum of 4 quarters · filed 2016-04-20 | ||||
| 2014-12-31 | $434.75K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $635.12K derived: sum of 2 quarters · filed 2016-03-28 | $595.28K derived: sum of 3 quarters · filed 2016-03-28 | $621.28K 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | $200.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $160.53K derived: sum of 2 quarters · filed 2015-11-02 | $186.53K 10-Q · filed 2015-11-02 | $238.07K derived: sum of 4 quarters · filed 2015-11-02 | ||||
| 2014-06-30 | -$39.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$13.83K 10-Q · filed 2015-07-30 | $37.71K derived: sum of 3 quarters · filed 2015-07-30 | $58.67K derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-03-31 | $26.00K 10-Q · filed 2015-05-04 | $77.54K derived: sum of 2 quarters · filed 2015-05-04 | $98.51K derived: sum of 3 quarters · filed 2015-05-04 | |||||
| 2013-12-31 | $51.54K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $72.50K derived: sum of 2 quarters · filed 2015-03-23 | $80.94K 10-K · filed 2015-03-23 | |||||
| 2013-09-30 | $20.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $29.40K 10-Q · filed 2014-10-30 | ||||||
| 2013-06-30 | $8.44K 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |